What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001290162
Total reported value
$1.7B
$1.7B
33 檔
50.1%
The Q2 2024 SEC filing reveals that QVT Financial LP held a total portfolio value of $1.7B, covering 33 public equity positions.
During Q2 2024, QVT Financial LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ROIV, MP, ECO) accounted for 50.1% of total reported equity market value during Q2 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 66.32% | -1.68% | — | |
| 2 | MP | Mp Materials CORP | Stock-Materials | 4.18% | — | -9.85% | |
| 3 | ECO | Okeanis Eco Tankers Corp. | Stock-Other | 3.87% | -0.97% | — | |
| 4 | GS | Goldman Sachs Group Inc | Stock-Financials | 3.14% | -0.62% | -7.78% | |
| 5 | NXST | Nexstar Media Group Inc | Stock-Comm Services | 2.59% | +0.03% | — | |
| 6 | NNI | Nelnet Inc-cl A | Stock-Other | 2.18% | -0.38% | — | |
| 7 | ATEX | Anterix Inc | Stock-Other | 1.88% | +0.91% | — | |
| 8 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 1.83% | +0.29% | — | |
| 9 | LILA | Liberty Latin America Ltd. | Stock-Other | 1.58% | -0.24% | — | |
| 10 | NYT | New York Times Co-a | Stock-Comm Services | 1.53% | -0.64% | — | |
| 11 | MMYT | MakeMyTrip Limited | Stock-Other | 1.52% | — | -40.00% | |
| 12 | MMYT 0 02-15-28Bond | Makemytrip Limited | Bond | 1.35% | -0.56% | EXIT | |
| 13 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.31% | — | — | |
| 14 | SEALTD 0.25 09-15-26Bond | Sea LTD | Bond | 1.23% | — | +200.00% | |
| 15 | TRML | Tourmaline Bio Inc | Stock-Other | 0.86% | — | -25.00% | |
| 16 | NIO 0.5 02-01-27Bond | Nio Inc | Bond | 0.76% | — | — | |
| 17 | ALLT | Allot Ltd. | Stock-Other | 0.62% | +0.18% | +16.28% | |
| 18 | BHVN | Biohaven Ltd. | Stock-Other | 0.55% | +0.20% | — | |
| 19 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.51% | — | — | |
| 20 | SMMT | Summit Therapeutics Inc | Stock-Other | 0.42% | -0.19% | — | |
| 21 | VTNRUSD | Vertex Energy Inc | Stock-Other | 0.41% | — | +58.12% | |
| 22 | HTHT 3 05-01-26Bond | H World Group LTD | Bond | 0.28% | — | — | |
| 23 | INFA1EUR | Informatica Inc - Class A | Stock-Other | 0.26% | — | +232.85% | |
| 24 | BILI 0.5 12-01-26Bond | Bilibili Inc | Bond | 0.24% | — | — | |
| 25 | NTES | Netease Inc-adr | Stock-Comm Services | 0.19% | — | — | |
| 26 | GTN | Gray Media Inc | Stock-Other | 0.14% | -0.02% | — | |
| 27 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 0.08% | — | — | |
| 28 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.05% | — | — | |
| 29 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 0.03% | — | — | |
| 30 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 0.03% | — | — | |
| 31 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.03% | — | — | |
| 32 | ✓ | Mersana Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 33 | ✓ | Boa Acquisition CORP | Stock-Other | — | — | — |
According to official SEC Form 13F filings, QVT Financial LP reported a total U.S. public equity portfolio value of $1.7B across 33 disclosed positions in Q2 2024.
During Q2 2024, QVT Financial LP's top holdings by market value included ROIV (66.3%)、MP (4.2%)、ECO (3.9%). The largest single position, ROIV, represented 66.3% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q2 2024, QVT Financial LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.